Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Department of Brain Sciences, Imperial College London, London, UK.
Brain Behav. 2021 Aug;11(8):e2250. doi: 10.1002/brb3.2250. Epub 2021 Jun 14.
Hemorrhagic transformation (HT) after stroke, related to atrial fibrillation (AF), is a frequent complication, and it can be associated with a delay in the (re-)initiation of oral anticoagulation therapy. We investigated the effect of the presence and severity of white matter disease (WMD) on early HT after stroke related to AF.
A consecutive series of patients with recent (<4 weeks) ischemic stroke and AF, treated at the Hyper Acute Stroke Unit of the Imperial College London between 2010 and 2017, were enrolled. Patients with brain MRI performed 24-72 h from stroke onset and not yet started on anticoagulant treatment were included. WMD was graded using the Fazekas score.
Among the 441 patients eligible for the analysis, 91 (20.6%) had any HT. Patients with and without HT showed similar clinical characteristics. Patients with HT had a larger diffusion-weighted imaging (DWI) infarct volume compared to patients without HT (p < .001) and significant difference in the distribution of the Fazekas score (p = .001). On multivariable analysis, HT was independently associated with increasing DWI infarct volume (odd ratio (OR), 1.03; 95% confidence interval (CI), 1.01-1.05; p < .001), higher Fazekas scores (OR, 1.94; 95% CI, 1.47-2.57; p < .001) and history of previous intracranial hemorrhage (OR, 4.80; 95% CI, 1.11-20.80; p = .036).
Presence and severity of WMD is associated with increased risk of development of early HT in patients with stroke and AF. Further evidence is needed to provide reliable radiological predictors of the risk of HT in cardioembolic stroke.
与心房颤动(AF)相关的中风后出血性转化(HT)是一种常见的并发症,可能会导致口服抗凝治疗的延迟重新开始。我们研究了脑白质疾病(WMD)的存在和严重程度对与 AF 相关的中风后早期 HT 的影响。
连续纳入 2010 年至 2017 年期间在伦敦帝国学院 Hyper Acute Stroke Unit 接受治疗的近期(<4 周)缺血性中风和 AF 患者。纳入在中风发作后 24-72 小时内进行脑部 MRI 且尚未开始抗凝治疗的患者。使用 Fazekas 评分评估 WMD。
在 441 名符合分析条件的患者中,有 91 名(20.6%)发生了任何 HT。有 HT 和无 HT 的患者表现出相似的临床特征。与无 HT 的患者相比,有 HT 的患者的弥散加权成像(DWI)梗死体积更大(p <.001),且 Fazekas 评分分布存在显著差异(p =.001)。多变量分析显示,HT 与 DWI 梗死体积增大独立相关(比值比(OR),1.03;95%置信区间(CI),1.01-1.05;p <.001)、Fazekas 评分升高(OR,1.94;95% CI,1.47-2.57;p <.001)和既往颅内出血史(OR,4.80;95% CI,1.11-20.80;p =.036)。
WMD 的存在和严重程度与中风和 AF 患者发生早期 HT 的风险增加相关。需要进一步的证据来提供可靠的影像学预测因子,以预测心源性中风的 HT 风险。